Business Context and Reporting Period
Company: Chemed Corporation
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Quarter and six months ended June 30, 1994
Business Overview: Chemed operates through four primary segments: National Sanitary Supply, Roto-Rooter, Veratex, and Patient Care (acquired January 1, 1994). The company provides sanitary supplies, plumbing services, and home health care services.
Key Financial Metrics
| Metric (in thousands) | Q2 1994 | Q2 1993 | 6 Months 1994 | 6 Months 1993 |
|---|---|---|---|---|
| Total Sales & Service Revenues | $161,384 | $127,241 | $313,453 | $247,760 |
| Income from Operations | $6,466 | $5,300 | $12,136 | $9,192 |
| Net Income | $8,017 | $5,551 | $13,694 | $11,280 |
| Earnings Per Share (Net) | $0.81 | $0.57 | $1.39 | $1.15 |
| Operating Margin | 4.0% | 4.2% | 3.9% | 3.7% |
| Cash & Equivalents (End of Period) | $10,397 | $14,615 (Dec 93) | $10,397 | $14,527 (Dec 93) |
| Total Debt (Current + Long-term) | $140,472 | $128,747 (Dec 93) | $140,472 | $128,747 (Dec 93) |
| Net Cash from Operating Activities | N/A | N/A | $4,679 | $10,130 |
Note: Operating margins calculated as Income from Operations divided by Total Sales & Service Revenues.
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 27% year-over-year for both the quarter and six-month periods. This growth was driven primarily by the acquisition of Patient Care Inc. (contributing $17.6M in Q2) and the Roto-Rooter segment (up 45% in Q2).
- Profitability: Net income increased 44% in Q2 1994 compared to Q2 1993. However, the consolidated operating margin declined slightly from 5.3% to 5.1% in Q2 due to lower margins in the Roto-Rooter service contract business.
- Investment Gains: "Other income" increased significantly due to realized gains on the sale of investments (Omnicare and EXEL, Ltd.), totaling $4.3M pretax in Q2 1994 versus $3.1M in Q2 1993.
- Discontinued Operations: The company recorded a $2.3M after-tax gain in Q2 1994 from the resolution of tax issues related to operations discontinued in 1991.
- Cash Flow: Net cash provided by operating activities decreased to $4.7M for the six months ended June 30, 1994, compared to $10.1M in the prior year, largely due to an $8.3M increase in accounts receivable.
Guidance, Outlook, and Risks
- Acquisition Integration: Management expects the consolidation of purchasing functions between Roto-Rooter and the acquired Encore Services Systems to lower material costs in the future.
- Contingent Payments: The acquisition of Patient Care includes potential additional cash payments of up to $10.4M contingent on earnings through 1995. A $3.8M contingent payment for Encore was accrued in Q2 1994.
- Regulatory Matters: An application for the transfer of ownership of one region of Patient Care is pending with a state regulatory agency and is expected to be approved in 1994.
- Accounting Changes: The company adopted SFAS 115 effective Jan 1, 1994, classifying certain securities as "trading" or "available for sale," resulting in a $7.4M unrealized appreciation recorded in equity.
- Liquidity: The company maintains approximately $36.8M in unused lines of credit and entered into a $10M term loan in March 1994 to finance the Patient Care acquisition.
Investor Verification Checklist
- Acquisition Impact: Verify the contribution of Patient Care and Encore to revenue growth versus organic growth in core segments.
- Investment Gains: Assess the sustainability of earnings given the significant portion derived from one-time gains on the sale of Omnicare and EXEL investments.
- Working Capital: Investigate the $8.3M increase in accounts receivable and its impact on future cash flow collection.
- Contingent Liabilities: Monitor the performance of Patient Care to determine if the $10.4M contingent payment will be triggered.
- Margin Trends: Review the Roto-Rooter segment's service contract margins to confirm if cost consolidation efforts are improving profitability.